253 related articles for article (PubMed ID: 28500174)
1. Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.
Adedinsewo D; Xu J; Agasthi P; Oderinde A; Adekeye O; Sachdeva R; Rust G; Onwuanyi A
Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004573. PubMed ID: 28500174
[TBL] [Abstract][Full Text] [Related]
2. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.
Freeman JV; Reynolds K; Fang M; Udaltsova N; Steimle A; Pomernacki NK; Borowsky LH; Harrison TN; Singer DE; Go AS
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):49-58. PubMed ID: 25414270
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
Gheorghiade M; Fonarow GC; van Veldhuisen DJ; Cleland JG; Butler J; Epstein AE; Patel K; Aban IB; Aronow WS; Anker SD; Ahmed A
Eur Heart J; 2013 May; 34(20):1489-97. PubMed ID: 23592708
[TBL] [Abstract][Full Text] [Related]
4. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.
Turakhia MP; Santangeli P; Winkelmayer WC; Xu X; Ullal AJ; Than CT; Schmitt S; Holmes TH; Frayne SM; Phibbs CS; Yang F; Hoang DD; Ho PM; Heidenreich PA
J Am Coll Cardiol; 2014 Aug; 64(7):660-8. PubMed ID: 25125296
[TBL] [Abstract][Full Text] [Related]
5. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
[TBL] [Abstract][Full Text] [Related]
6. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
[TBL] [Abstract][Full Text] [Related]
7. Interaction between digoxin and dronedarone in the PALLAS trial.
Hohnloser SH; Halperin JL; Camm AJ; Gao P; Radzik D; Connolly SJ;
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1019-25. PubMed ID: 25378467
[TBL] [Abstract][Full Text] [Related]
8. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
Gonzalez-Loyola F; Abellana R; Verdú-Rotellar JM; Bustamante Rangel A; Clua-Espuny JL; Muñoz MA
Eur J Clin Invest; 2018 Nov; 48(11):e13014. PubMed ID: 30091171
[TBL] [Abstract][Full Text] [Related]
9. Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry.
Gao Y; Chang S; Du X; Dong J; Xu X; Zhou Y; Lip GYH; Ma C
Am J Cardiovasc Drugs; 2019 Dec; 19(6):579-587. PubMed ID: 31077081
[TBL] [Abstract][Full Text] [Related]
10. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
[TBL] [Abstract][Full Text] [Related]
11. Digoxin and mortality in atrial fibrillation: a prospective cohort study.
Hallberg P; Lindbäck J; Lindahl B; Stenestrand U; Melhus H;
Eur J Clin Pharmacol; 2007 Oct; 63(10):959-71. PubMed ID: 17684738
[TBL] [Abstract][Full Text] [Related]
12. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
[TBL] [Abstract][Full Text] [Related]
13. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
Pastori D; Farcomeni A; Bucci T; Cangemi R; Ciacci P; Vicario T; Violi F; Pignatelli P
Int J Cardiol; 2015 Feb; 180():1-5. PubMed ID: 25460369
[TBL] [Abstract][Full Text] [Related]
14. Digoxin and Mortality in Patients With Atrial Fibrillation.
Lopes RD; Rordorf R; De Ferrari GM; Leonardi S; Thomas L; Wojdyla DM; Ridefelt P; Lawrence JH; De Caterina R; Vinereanu D; Hanna M; Flaker G; Al-Khatib SM; Hohnloser SH; Alexander JH; Granger CB; Wallentin L;
J Am Coll Cardiol; 2018 Mar; 71(10):1063-1074. PubMed ID: 29519345
[TBL] [Abstract][Full Text] [Related]
15. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
[TBL] [Abstract][Full Text] [Related]
16. Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis.
Elayi CS; Shohoudi A; Moodie E; Etaee F; Guglin M; Roy D; Khairy P;
Int J Cardiol; 2020 Aug; 313():48-54. PubMed ID: 32320783
[TBL] [Abstract][Full Text] [Related]
17. Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
Whitbeck MG; Charnigo RJ; Khairy P; Ziada K; Bailey AL; Zegarra MM; Shah J; Morales G; Macaulay T; Sorrell VL; Campbell CL; Gurley J; Anaya P; Nasr H; Bai R; Di Biase L; Booth DC; Jondeau G; Natale A; Roy D; Smyth S; Moliterno DJ; Elayi CS
Eur Heart J; 2013 May; 34(20):1481-8. PubMed ID: 23186806
[TBL] [Abstract][Full Text] [Related]
18. Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
Schmiegelow MD; Pedersen OD; Køber L; Seibæk M; Abildstrøm SZ; Torp-Pedersen C
BMC Cardiovasc Disord; 2011 May; 11():19. PubMed ID: 21569543
[TBL] [Abstract][Full Text] [Related]
19. Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
Yoshihisa A; Sato Y; Sato T; Suzuki S; Oikawa M; Takeishi Y
BMC Cardiovasc Disord; 2018 Jan; 18(1):11. PubMed ID: 29368593
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of the heart rate reserve in patients with permanent atrial fibrillation treated according to a strict rate-control strategy.
De Schryver N; Scavée C; Marchandise S; Pasquet A; de Meester C; le Polain de Waroux JB
Europace; 2014 Aug; 16(8):1125-30. PubMed ID: 24599938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
